↓ Skip to main content

Predicting survival after radiosurgery in patients with lung cancer brain metastases using deep learning of radiomics and EGFR status

Overview of attention for article published in Physical and Engineering Sciences in Medicine, March 2023

Mentioned by

twitter
3 X users

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Predicting survival after radiosurgery in patients with lung cancer brain metastases using deep learning of radiomics and EGFR status
Published in
Physical and Engineering Sciences in Medicine, March 2023
DOI 10.1007/s13246-023-01234-7
Pubmed ID
Authors
Abstract

The early prediction of overall survival (OS) in patients with lung cancer brain metastases (BMs) after Gamma Knife radiosurgery (GKRS) can facilitate patient management and outcome improvement. However, the disease progression is influenced by multiple factors, such as patient characteristics and treatment strategies, and hence satisfactory performance of OS prediction remains challenging. Accordingly, we proposed a deep learning approach based on comprehensive predictors, including clinical, imaging, and genetic information, to accomplish reliable and personalized OS prediction in patients with BMs after receiving GKRS. Overall 1793 radiomic features extracted from pre-GKRS magnetic resonance images (MRI), clinical information, and epidermal growth factor receptor (EGFR) mutation status were retrospectively collected from 237 BM patients who underwent GKRS. DeepSurv, a multi-layer perceptron model, with 4 different aggregation methods of radiomics was applied to predict personalized survival curves and survival status at 3, 6, 12, and 24 months. The model combining clinical features, EGFR status, and radiomics from the largest BM showed the best prediction performance with concordance index of 0.75 and achieved areas under the curve of 0.82, 0.80, 0.84, and 0.92 for predicting survival status at 3, 6, 12, and 24 months, respectively. The DeepSurv model showed a significant improvement (p < 0.001) in concordance index compared to the validated lung cancer BM prognostic molecular markers. Furthermore, the model provided a novel estimate of the risk-of-death period for patients. The personalized survival curves generated by the DeepSurv model effectively predicted the risk-of-death period which could facilitate personalized management of patients with lung cancer BMs.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Doctoral Student 3 12%
Student > Ph. D. Student 3 12%
Student > Bachelor 2 8%
Student > Master 2 8%
Professor 1 4%
Other 1 4%
Unknown 13 52%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 8 32%
Computer Science 2 8%
Physics and Astronomy 1 4%
Neuroscience 1 4%
Unknown 13 52%